I reported previously on the neuroAD transcranial magnetic stimulation (TMS) and cognitive training from Israel’s Neuronix (see here). NeuroAD now has CE approval and is commercially available in Israel, Europe and Asia. US FDA approval is subject to results of latest trials.
http://www.israel21c.org/drug-free-alzheimers-treatment-to-seek-fda-approval/